Reviews of Cabot Investing Advice and Advisories

Cabot Investing Advice reviewed by our subscribers:

Cabot Analysts
We are always happy to get feedback from our customers—here’s what they have to say. Click the links to see reviews of individual newsletters and for general reviews of Cabot Investing Advice and our advisories.

Cabot Investing Advice Reviews

General reviews from subscribers to one or more Cabot advisories»

Cabot Benjamin Graham Value Investor Reviews

Reviews from subscribers to Cabot Benjamin Graham Value Investor»

Cabot Dividend Investor Reviews

Reviews from subscribers to Cabot Dividend Investor»

Cabot Growth Investor Reviews

Reviews from subscribers to Cabot Growth Investor»

Reviews of the Cabot Investors Conference

Reviews from recent Cabot Investors Conference attendees»

Cabot's Low-Priced Stock Report

Reviews of the annual special report, Cabot's Low-Priced Stock Report»

Cabot Options Trader Reviews

Reviews from subscribers to Cabot Option Trader and Cabot Option Trader Pro»

Cabot Small-Cap Confidential Reviews

Reviews from subscribers to Cabot Small-Cap Confidential»

Cabot Top Ten Trader Reviews

Reviews from subscribers to Cabot Top Ten Trader»

Cabot Wealth Advisory Reviews

Reviews from subscribers to Cabot Wealth Advisory, Cabot's free advisory»

Cabot China & Emerging Markets Report Reviews

Reviews from subscribers to Cabot China & Emerging Markets Report»

Cabot Stock of the Month Reviews

Reviews from subscribers to Cabot Stock of the Month»

Stock Picks

Ross Stores

McKesson (MCK) distributes ethical and proprietary drugs, surgical supplies and health and beauty products throughout North America to the healthcare industry. The company also provides technical consulting services to biotech and pharmaceutical manufacturers.

Carnival Cruise Lines

Having just returned from vacation, Tim Lutts is thinking of the millions of baby-boomers who are spending more and more money on leisure travel, particularly on cruises, an industry that is dominated by a few big players.

China Biologic Products

Paul Goodwin advises putting this stock on your watch list.

Cabot Wealth Advisory

Do Your Stocks Have Borrowing Trouble?

By Nancy Zambell on July 28, 2015

Hostess is making news today as it is issuing $1.23 million in term loans—most of which will go toward paying $905 million in a special dividend to its private shareholders—which I may add, is also more than two times what the buyers paid for this tasty snack business, and triples the company’s debt. According to Bloomberg, these types of deals grew to nearly $16 billion in the second quarter, the highest level in the past 12 months. I’m not making a judgment for or against this action. I just want to make a point that this debt, or leverage recapitalization—spurred by low interest rates—is increasingly becoming a method in which private equity holders get their money back—without selling the business. But it does burden the company with additional debt, which isn’t going to fund company expansion or operations.Read More >

Sell Apple

By Timothy Lutts on July 27, 2015

Today, I’m writing on a MacBook Pro. This morning I did my morning crossword puzzle on my iPad. All day long, my iPhone is by my side. My home Wi-Fi comes from Apple AirPorts. And some nights, I stream entertainment through my Apple TV. In short, I love Apple products, and I expect to continue using them for many more years. But one of the most important market truisms is this: “The company is not the stock.”Read More >

Sunny Days

By Paul Goodwin on July 24, 2015

Every year, usually on a Thursday in July, most of the Cabot crew gathers in Salem, jumps into cars and heads north. With bathroom breaks and a stop to purchase refreshing beverages (ahem), the group drives through New Hampshire’s tiny seacoast neck and winds up in Kittery, Maine, at the Chauncey Creek Lobster Pound. There, lobsters, baked beans, coleslaw, steamers, mussels and (importantly) chips are consumed and the store of tissue-restoring beverages is significantly reduced.Read More >